Introduction
============

There is an urgent need to develop new antifungal molecules with properties and mechanisms of action different from existing ones ([@B7]; [@B11]). Antimicrobial peptides and proteins (AMPs) have been found in a broad variety of species ([@B19]) and are candidates for the development of novel therapeutic compounds ([@B49]; [@B6]; [@B13]) including antifungals ([@B38]). A remarkable group of AMPs are the antifungal proteins (AFPs) of fungal origin. AFPs belong to the broad class of defensins and are produced by some species of filamentous Ascomycetes, mostly from the genus *Aspergillus* and *Penicillium* ([@B27]; [@B28]; [@B14]; [@B39]). AFPs are small (∼50 amino acid residues), secreted, amphipathic, cationic and cysteine-rich proteins (CRPs) that contain six to eight cysteine residues and fold into compact disulfide-stabilized structures with five β-strands, which confer high stability under adverse biochemical and biophysical conditions ([@B4]). All the AFPs contain the so-called γ-core, a three-dimensional peptide signature present in antimicrobial CRPs spanning biological kingdoms ([@B48]). One of the most studied AFPs is the *Penicillium chrysogenum* PAF protein (55 amino acids in length) that can be easily purified from the culture supernatants of the producer fungus *P. chrysogenum* ([@B27]). PAF inhibits the growth of filamentous human and plant pathogenic fungi at μM concentrations and is non-toxic to mammalian cells *in vitro* ([@B27]) and *in vivo* ([@B33]).

A significant diversity of AFP-like genes and proteins are widespread in Ascomycetes, with genomes that encode up to three different sequence-related AFPs ([@B15]; [@B16]; [@B42]), providing a rich source of potentially divergent antifungals. Bioinformatic and phylogenetic analyses suggested the classification of the different AFP-like sequences in at least three different classes: A, B, and C ([@B16]). Notably, these fungal genomes code for a different number of AFP-like proteins that belong to diverse classes; *P. chrysogenum* encodes three classes (A, B, and C), *Penicillium roqueforti* two classes (A and C), and *Penicillium digitatum* just one (B). There is also a significant variation in the amount of AFP produced by each fungus and the growth conditions required to achieve maximum yields. Thus, the above-mentioned PAF protein is secreted in large amounts by *P. chrysogenum* ([@B27]), while the NFAP and NFAP2 from *Neosartorya fischeri* are produced in modest amounts ([@B21]; [@B45]). An extreme example of this scenario is that of the previously characterized *afpB* gene identified in the genome of the phytopathogenic fungus *P. digitatum* ([@B16]). Attempts to identify the class B AFP (AfpB) in the small size protein fraction secreted by the fungus were not successful, even in the constitutive expressing strains that produce up to 1,000 times more *afpB* mRNA than the wild-type ([@B16]). This unexpected finding was one of the main reasons that led us to conduct the study reported here.

In-depth understanding of the structure and mode of action of AFPs is required for their potential future application as antifungal compounds. In addition, AFP and AFP-like sequences are a rich source for the identification and rational design of novel antimicrobial peptides with improved properties ([@B26], [@B25]). Finally, the structural domains that account for the antifungal activity of AFPs remain to be fully identified and characterized. In this study, the structure of the putative *P. digitatum* AfpB protein was predicted by *in silico* molecular modeling to aid in the design of peptides based on the AfpB primary sequence and structure, whose antifungal activity was demonstrated and characterized. With this rational approach, peptides that have moderate but specific antifungal activity were identified within the AfpB and PAF amino acid sequences. Importantly, the previously characterized PAF26 hexapeptide ([@B30]) showed positive synergistic interaction with the AFP-derived peptides and the PAF protein.

Materials and Methods {#s1}
=====================

Strains and Media
-----------------

The fungal strains used in this study are *P. digitatum* CECT20796, *P. chrysogenum* Q176, *Botrytis cinerea* CECT2100, *Fusarium oxysporum* 4287, and *Aspergillus niger* CBS 120.49. Fungi were cultured on potato dextrose agar (Difco-BD Diagnostics, Sparks, MD, USA) plates for 7--10 days at 24°C with the exception of *F. oxysporum*, which was cultured on potato dextrose broth (PDB; Difco-BD Diagnostics) at 28°C for 4 days with shaking. Conidia (mitotic asexual spores) were collected, filtered, and adjusted to the appropriate concentration. For antibacterial assays, the Gram-negative bacterium *Escherichia coli* JM109 was grown in Luria-Bertani (LB) medium at 37°C with shaking.

*In silico* Calculations and AfpB Structure Prediction
------------------------------------------------------

The SWISS-MODEL program^[1](#fn01){ref-type="fn"}^ ([@B1]) was used to predict the 3D structure of the *P. digitatum* antifungal protein AfpB ([@B16]) using the *P. chrysogenum* antifungal protein PAF as template (PDB ID 2MHV; [@B12]). The model obtained was refined using the ModRefiner tool^[2](#fn02){ref-type="fn"}^ ([@B47]) and subsequently validated by RAMPAGE^[3](#fn03){ref-type="fn"}^ to ensure that all the amino acids of the AfpB model were located inside the favored and energetically allowed regions according to the Ramachandran plot ([@B24]).

The theoretical molecular mass, the pI, and the GRAVY of the mature AfpB protein and peptides derived therefrom were examined with the Compute pI/Mw and ProtParam tools of the ExPASy Proteomics Server^[4](#fn04){ref-type="fn"}^ ([@B17]), respectively. The signal peptide and disulfide bridges of the mature protein were predicted using the SignalP 4.0 Server^[5](#fn05){ref-type="fn"}^ ([@B34]) and the DISULFIND software^[6](#fn06){ref-type="fn"}^ ([@B9]), respectively. The 3D model of AfpB was visualized by Chimera software ([@B35]).

PAF Protein and Synthetic Peptides
----------------------------------

The PAF protein was produced by *P. chrysogenum* and purified as previously described ([@B4]; [@B41]). All the peptides used in this work were synthetic and purchased at \>95% purity from GenScript (Piscataway, NJ, USA) wherein they were synthesized by solid phase methods using *N*-(9-fluorenyl) methoxycarbonyl (Fmoc) chemistry. The sequences of the peptides used and their physicochemical properties are listed in **Table [1](#T1){ref-type="table"}**. Peptides PAF109, PAF112, PAF118, and PAF119 derived from the AfpB protein, and peptide PAF116 derived from the PAF protein, were synthetized with a disulfide bond linking the two cysteine residues, respectively. Stock solutions of peptides were prepared at 5.12 mM in 10 mM 3-(*N*-morpholino)-propanesulfonic acid (MOPS; Sigma-Aldrich, St. Louis, MO, USA) pH 7 and stored at -20°C. The peptide concentrations were prepared by dissolving a given peptide amount (mg) in MOPS buffer (mL), considering the purity of each of the peptides provided by the manufacturer. Additionally, the PAF26 concentration was confirmed spectrophotometrically by measuring the absorbance at 280 nm (𝜀280 = 5600 M^-1^ cm^-1^ for W residue).

###### 

Amino acid sequences and properties of the peptides used in this study.

  ID       Sequence^1^                        MM (Da)   Net charge   pI     GRAVY    Source
  -------- ---------------------------------- --------- ------------ ------ -------- ------------------------
  PAF26    RKKWFW                             950.2     3.0          11.2   -1.883   [@B23]
  PAF109   GQ[C]{.ul}SLKHNT[C]{.ul}T          1189.3    1.1          8.1    -0.718   AfpB (*P. digitatum*)
  PAF112   N[C]{.ul}GSAANKRAKSDRHH[C]{.ul}E   1982.1    2.2          8.9    -1.600   AfpB (*P. digitatum*)
  PAF113   NAGSAANKRAKSDRHHAE                 1920.0    2.2          10.0   -1.678   AfpB (*P. digitatum*)
  PAF118   NT[C]{.ul}TYLKGGRNVIVN[C]{.ul}G    1810.1    2.0          8.9    -0.065   AfpB (*P. digitatum*)
  PAF119   H[C]{.ul}EYDEHHRRVD[C]{.ul}Q       1824.9    -1.7         5.8    -2.014   AfpB (*P. digitatum*)
  PAF116   K[C]{.ul}PKFDNKKATKDNNK[C]{.ul}T   2081.4    4.0          9.5    -1.906   PAF (*P. chrysogenum*)

1

Underlined cysteine residues in PAF109, PAF112, PAF116, PAF118, and PAF119 are linked by disulfide bonds.

ECD Spectroscopy
----------------

Electronic circular dichroism (ECD) spectroscopic measurements were performed in the 195--260 nm wavelength range (far-UV) to determine the secondary structure of the AfpB-derived peptides. Peptide samples were dissolved in H~2~O, and in a 50:50 trifluoroethanol (TFE):H~2~O mixture at approximately 0.1 mg/mL concentration and measured in a 0.1 cm path-length quartz cuvette using a Jasco J-815 spectropolarimeter at a scan speed of 100 nm/s at 25°C. Solvent spectra were measured similarly and subtracted from the corresponding spectra of peptides. Ellipticity data were given in mdeg units.

Antimicrobial Activity Assays
-----------------------------

Growth inhibition assays were performed in 96-well microtiter plates (Nunc, Roskilde, Denmark) in a total volume of 100 μL as described previously ([@B23]). A volume of 90 μL of fungal conidia (2.5 × 10^4^ conidia/mL) or bacterial cells (5 × 10^5^ cells/mL) in appropriate growth media \[1/20 diluted PDB containing 0.01% (w/v) chloramphenicol for fungi or 1/10 diluted LB for bacteria\] was mixed in each well with 10 μL of 10× concentrated peptide or PAF protein solution from serial twofold dilutions (from 1 to 128 μM for PAF109, PAF112, PAF113, PAF116, PAF118, and PAF119; from 0.25 to 4 μM for PAF26; and from 1 to 16 μM for the protein PAF from *P. chrysogenum*). All samples were prepared in triplicate. Plates were statically incubated for 72 h at the optimal temperature of each microorganism. Growth was determined by measuring the optical density (OD) at 600 nm (OD~600~) using a Multiskan Spectrum plate spectrophotometer (Thermo Electron Corporation, Vantaa, Finland), and the OD~600~ mean and SD were calculated. Dose--response curves were generated from measurements after 72 h for fungi, and 48 h for *E. coli*. These experiments were repeated at least twice. The minimum inhibitory concentration (MIC) is the peptide concentration that completely inhibited growth in all the experiments performed.

For assays of synergy, different combinations of peptides and concentrations were tested in 96-well microtiter plates. Ten microliters of two different 10× concentrated peptides were mixed in the same well with 80 μL of *P. digitatum* conidia prepared and grown as above (total volume 100 μL). Plates were statically incubated for 72 h at 24°C. Data are expressed as OD~600~ mean ± SD of three replicates. Sub-MICs for each peptide were: 1--32 μM for PAF112, 1--16 μM for PAF118, 1--8 μM for PAF116, and 0.25--2 μM for PAF26. Similarly, the interaction between the PAF protein from *P. chrysogenum* and the PAF26 peptide was tested against *A. niger*, *P. chrysogenum*, and *P. digitatum*.

Proteolytic Digestion Assays
----------------------------

The proteolytic digestion assays were performed as described ([@B10]; [@B22]) with minor modifications. Peptides (5 μM) were dissolved in 10 mM MOPS pH 7 and digested with 5 μg/mL of recombinant proteinase K (2 U/mg; Roche, Mannheim, Germany) at 30°C. Aliquots were withdrawn from the reaction mixtures at 0, 1, 2, and 24 h of incubation and immediately heated at 80°C for 10 min to inactivate the enzyme. Two replicates were prepared for each treatment, and the experiments were repeated at least twice.

Analyses of peptide digests were conducted by RP-HPLC using a Waters system (Waters Corporation, Milford, MA, USA) equipped with a 1525 Binary HPLC pump, a 2996 Photodiode Array Detector, and a 717 plus Autosampler. A Symmetry C18 column (4.6 mm × 150 mm, 5 μm, Waters Corporation) kept at 40°C was operated at a flow rate of 1 mL/min. Peptides were eluted with a linear gradient of solvent B \[acetonitrile with 0.1% trifluoroacetic acid (TFA)\] in solvent A (water with 0.1% TFA) 0--40% in 20 min and detected at 214 nm.

Statistical Analysis
--------------------

All the statistical analyses carried out to determine the synergistic interactions were performed using STATGRAPHICS Centurion 16.1.17^[7](#fn07){ref-type="fn"}^. The significant differences between sets of data were determined by a bi-factorial ANOVA and Tukey's honestly significant difference (HSD) test. Significance was regarded as *p* \< 0.01.

Results
=======

AfpB Structural Modeling
------------------------

*In silico* translation of the *afpB* gene (PDIG_68840) shows that the AfpB primary structure contains 92 amino acid residues ([@B16]). A signal peptide and a pro-peptide (35 residues in total) are predicted to be cleaved from the N-terminal end of the protein, liberating the mature AfpB which is a small basic CRP consisting of 57 amino acid residues (**Figure [1A](#F1){ref-type="fig"}**). It has a calculated molecular mass of 6.46 kDa, a pI value of 9.06 and a GRAVY of -1.084. The dextromeric isoform of the γ-core with the consensus sequence GXCX~3-9~C ([@B48]) is present near the N-terminus (**Figure [1A](#F1){ref-type="fig"}**, boxed). The structure of mature AfpB was predicted by homology modeling using the SWISS-MODEL online resource, which selected the protein PAF from *P. chrysogenum* as template for prediction (PDB ID 2MHV; [@B12]), and refined using the ModRefiner tool (**Figure [1](#F1){ref-type="fig"}**). AfpB shows 33% amino acid identity and 44% similarity with the *P. chrysogenum* PAF. The refined AfpB model showed 56 of 57 (98%) of the amino acid residues positioned in energetically favored regions and one residue in energetically allowed regions according to the Ramachandran plot (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). The structural model of AfpB contains five antiparallel β-strands connected by three small loops and a big surface-exposed loop (Supplementary Figure [S2](#SM2){ref-type="supplementary-material"} and **Figure [1](#F1){ref-type="fig"}**). The antiparallel β-strands create two packed β-sheets and the six conserved cysteine residues form three disulfide bridges. The most probable disulfide bond pattern predicted by the DISULFIND software is "abcabc," between cysteines 7 and 35; 14 and 42; and 27 and 53 (see also **Figure [2A](#F2){ref-type="fig"}**), which also corresponds to the disulfide bond pattern determined in PAF ([@B44]).

![**Molecular modeling of the *P. digitatum* class B antifungal protein AfpB. (A)** Amino acid sequence alignment of AfpB and *P. chrysogenum* antifungal protein PAF. Cysteines are shadowed in black, other conserved amino acids in dark gray, and similar amino acids in light gray. Asterisks below sequences indicate conserved amino acids and colons similar amino acids. PAF and predicted AfpB β-sheets are labeled as β1 to β5 white arrows; and loops are labeled as L1 to L4. The γ-core motif is boxed. **(B)** Comparison of the tertiary structure of PAF (right) with the 3D molecular model obtained for AfpB (left).](fmicb-08-00592-g001){#F1}

![**Design and *in vitro* inhibitory activity of the synthetic AfpB-derived peptides. (A)** Amino acid sequence and net charge of the AfpB-derived peptides and their location in the protein sequence. Cysteine residues are shadowed in black. Asterisks and colon show conserved residues (see **Figure [1](#F1){ref-type="fig"}**). Arrows show the predicted β-sheets in AfpB. Black lines show the predicted disulfide bond pattern for AfpB (top) and the disulfide bonds in the AfpB-derived PAF109, PAF112, PAF118, and PAF119 (bottom). **(B)** Color-coded location of the AfpB-derived peptides in the modeled tertiary structure of AfpB. **(C--F)** Color-coded dose--response curves showing the antimicrobial activity of the peptides PAF109 (red circles), PAF118 (green squares), PAF112 (blue triangles), PAF119 (pink diamonds), and PAF26 (black circles), tested against *P. digitatum* **(C,E)**, *B. cinerea* **(D)**, and *E. coli* **(F)**. Dose--response curves show mean ± SD percentage of control growth of triplicate samples after 72 h of incubation at 24°C for fungi **(C--E)** and 48 h at 37°C for bacteria **(F)**.](fmicb-08-00592-g002){#F2}

Identification of AfpB-Derived Antifungal Peptides with Specific Antifungal Activity
------------------------------------------------------------------------------------

To identify putative antimicrobial motifs in AfpB, the cysteine-containing peptides PAF109, PAF112, PAF118, and PAF119 were derived from the AfpB sequence (**Table [1](#T1){ref-type="table"}**). Peptides (**Figure [2A](#F2){ref-type="fig"}**) were rationally designed with intramolecular disulfide bonds to promote folding into a loop or β-hairpin structure corresponding to the regions within the protein (**Figure [2B](#F2){ref-type="fig"}**). Peptide PAF109 is cationic, spans the first loop L1 between β-sheets β1 and β2, and corresponds to the conserved γ-core motif. PAF118, also with a positive net charge, includes the β2 and β3 sheets linked by a small loop (L2). PAF112 extents over the largest surface-exposed cationic loop L3 of the protein located between β3 and β4. In this peptide, the central Cys35 in L3 has been replaced by an alanine in order to promote disulfide bond formation between the terminal cysteine residues (**Figure [2A](#F2){ref-type="fig"}**). An additional peptide derived from this largest surface-exposed cationic loop L3, called PAF113, was designed. PAF113 corresponds to the linear version of the peptide PAF112 in which all cysteine residues were substituted by alanines. Finally, PAF119 has a negative net charge as opposed to the other three peptides, and includes the last two β-sheets (β4 and β5) linked by the small C-terminal loop (L4).

These AfpB-derived peptides were tested toward a selection of filamentous fungi that include plant pathogens (the citrus fruit-specific *P. digitatum*, the polyphagous *B. cinerea*, and the vascular wilt pathogen *F. oxysporum*), the PAF producer *P. chrysogenum*, and a strain from *A. niger* particularly sensitive to the PAF protein. The cationic peptides PAF112 and PAF118 showed antifungal activity and were completely inhibitory to *P. digitatum* and *B. cinerea*, with MIC values between 64 and 128 μM (**Figures [2C,D](#F2){ref-type="fig"}** and **Table [2](#T2){ref-type="table"}**). At lower concentrations (8--32 μM), PAF112 and PAF118 showed partial inhibition of the growth of these two fungi (**Figure [3](#F3){ref-type="fig"}** and data not shown). In the case of *A. niger* and *P. chrysogenum*, the PAF112 and PAF118 peptides significantly delayed fungal growth (**Figure [3](#F3){ref-type="fig"}** and data not shown). Even at low concentrations (8--32 μM) an inhibition was observed at short incubation times (24 h), although the peptides were not completely inhibitory at the highest concentration tested (128 μM) (**Figure [3](#F3){ref-type="fig"}**). In some experiments, PAF118 showed slightly higher antifungal activity than PAF112 according to the dose--response effect (see **Figures [2](#F2){ref-type="fig"}**, **[3](#F3){ref-type="fig"}**).

###### 

Minimum inhibitory concentration (MIC) of peptides studied in this work^1^.

  Microorganism              PAF26   PAF109   PAF112   PAF113   PAF118   PAF119   PAF116
  -------------------------- ------- -------- -------- -------- -------- -------- --------
  *P. digitatum* CECT20796   8       NI^2^    64       64       64       NI       32
  *B. cinerea* CECT2100      8       NI       128      128      64       NI       16
  *F. oxysporum* 4287        16      NI       NI       NI       NI       NI       NI
  *A. niger* CBS 120.49      8       NI       \>128    \>128    \>128    NI       --^3^
  *P. chrysogenum* Q176      16      NI       \>128    \>128    \>128    NI       --
  *E. coli* JM109            NI      NI       NI       NI       NI       NI       --

1

MIC values are shown in μM units for each fungus--peptide combination.

2

NI, no significant inhibition at the highest concentration tested (128 μM).

3

--, not tested.

![**Time-course inhibition of growth of filamentous fungi by synthetic peptides.** Time-course inhibition of growth of *P. digitatum* **(A)** and *A. niger* **(B)** in the presence of increasing concentrations of the synthetic peptides PAF26 (2, 4, and 8 μM), PAF112 (8, 32, and 128 μM), and PAF118 (8, 32, and 128 μM). Data are shown after 24, 48, and 72 h of incubation as indicated. Bars represent the mean value ± SD of the percentage of growth as compared to the 100% control that was defined for each fungus as the growth in the absence of peptide (C, control) at 72 h.](fmicb-08-00592-g003){#F3}

Regarding other peptides (**Figure [2](#F2){ref-type="fig"}**), PAF109 derived from the conserved γ-core did not show inhibitory activity at any of the concentrations tested. The anionic peptide PAF119 did not show activity either. None of the AfpB-derived peptides tested showed inhibitory effect against *F. oxysporum* at the maximum concentration used. This strain of *F. oxysporum* has shown comparatively higher tolerance to most of the peptides studied in our laboratory over the years ([@B22]).

The synthetic hexapeptide PAF26 is an antifungal peptide that was identified by a combinatorial approach against *P. digitatum* ([@B23]). PAF26 is a cationic tryptophan-rich peptide (**Table [1](#T1){ref-type="table"}**) that belongs to the cell-penetrating class of AMPs and whose mechanism of action has been characterized previously ([@B30]). PAF26 has specific activity for filamentous fungi showing MIC values below 10 μM and was therefore chosen as an internal control in this study. We found that peptides PAF112 and PAF118 are around one order of magnitude less active than PAF26 (**Figure [2E](#F2){ref-type="fig"}** and **Table [2](#T2){ref-type="table"}**). As occurs with PAF26, none of the AfpB-derived peptides showed antibacterial activity against *E. coli* (**Figure [2F](#F2){ref-type="fig"}**), which demonstrated the selective antifungal activity of PAF112 and PAF118 over the range of concentrations assayed.

Peptide PAF116 Derived from the *P. chrysogenum* Antifungal Protein PAF is Less Active than the Native Protein
--------------------------------------------------------------------------------------------------------------

Since it was impossible to detect AfpB in all the experiments conducted so far in our laboratory ([@B16]), we wanted to test whether peptides derived from AFPs could have antifungal activity similar to the native protein. Therefore, we designed the disulfide cyclized peptide PAF116 analogous to PAF112 but originating from the *P. chrysogenum* antifungal protein PAF, which was readily available (**Figure [4](#F4){ref-type="fig"}**). The sequence alignment of PAF112 and PAF116 showed low similarity (44%; **Figure [4A](#F4){ref-type="fig"}**). However, despite the sequence divergence between these two peptides, both shared comparable antifungal activity against *P. digitatum* (**Figure [4B](#F4){ref-type="fig"}**, top). As in the case of PAF112, PAF116 showed no antifungal activity against *F. oxysporum* (data not shown). In contrast, PAF116 exhibited higher antimicrobial activity than PAF112 against *B. cinerea* (**Table [2](#T2){ref-type="table"}**).

![**Comparative study of the AfpB-derived peptide PAF112 and the PAF-derived PAF116. (A)** Amino acid sequence alignment of PAF112 and PAF116. Cysteine conserved residues are shadowed in black, conserved residues in dark gray, and similar in light gray. Asterisks and colon show conserved residues (see **Figure [1](#F1){ref-type="fig"}**). **(B)** Dose--response curves of *P. digitatum* inhibition by the synthetic peptides PAF112 (blue triangles) and PAF116 (gray circles) (top), and by the peptide PAF116 (gray circles) and protein PAF from *P. chrysogenum* (white triangles) (bottom). Curves show mean ± SD OD~600~ of triplicate samples after 72 h of incubation at 24°C.](fmicb-08-00592-g004){#F4}

Additional assays were conducted to compare the antifungal activity of the peptide PAF116 and the parental protein PAF (**Figure [4B](#F4){ref-type="fig"}**, bottom). The results showed that PAF116 is less active than the PAF protein against *P. digitatum*. The MIC values were 32 μM for the peptide PAF116 and 8 μM for the PAF protein. This result leads us to propose that AfpB would be also more active than the peptides PAF112 or PAF118 derived from its primary sequence. In addition, it is demonstrated that *P. digitatum* is sensitive to the PAF protein from *P. chrysogenum*, which as the producer fungus is tolerant to this protein (**Table [3](#T3){ref-type="table"}**).

###### 

Synergistic interaction between PAF26 peptide and PAF protein.

  Strain                     PAF26 peptide^1^   PAF protein^1^   Interaction PAF26/PAF
  -------------------------- ------------------ ---------------- --------------------------------
  *P. digitatum* CECT20796   8                  8                Positive synergy (*p* \< 0.01)
  *P. chrysogenum* Q176      16                 NI^2^            No synergy
  *A. niger* CBS 120.49      8                  0.08             Positive synergy (*p* \< 0.01)

1

MIC (μM) are shown for each combination.

2

NI, no inhibition at the highest concentration tested (64 μM).

Synergistic Interactions
------------------------

In view of the above data we hypothesized that the combined action of different AfpB-derived peptides could mimic the activity of the native protein. To address our prediction, we designed and conducted a series of experiments in which different peptides were tested for synergy against *P. digitatum* (**Figure [5](#F5){ref-type="fig"}**). From all possible combinations of the four AfpB-derived peptides in groups of two, only PAF112 and PAF118 showed positive synergistic interaction when combined (**Figure [5](#F5){ref-type="fig"}** and data not shown). A multifactorial ANOVA test was conducted at different concentrations of PAF112 (from 1 to 32 μM), PAF118 (from 1 to 16 μM) and all possible concentration combinations of both, demonstrating the existence of an interaction (*p* \< 0.01). As example, the data from the combined action of 16 μM PAF112 and 1 μM PAF118 is shown (**Figure [5](#F5){ref-type="fig"}**, left). Single treatments of PAF112 or PAF118 did not result in a fungal growth significantly different from the control. However, the combined activity of both peptides resulted in significant inhibition of *P. digitatum* (*p* \< 0.01, **Figure [5](#F5){ref-type="fig"}**), in the range of the inhibition achieved by the PAF protein at 1 μM (**Figure [4B](#F4){ref-type="fig"}**). This observation leads us to suggest that these two motifs contribute to reach optimal activity of the native AfpB protein.

![**Synergistic interactions between AFP-derived peptides and PAF26.** Each of the four panels show the synergistic interactions between PAF112 and PAF118; PAF112 and PAF26; PAF118 and PAF26; and PAF116 and PAF26, tested against *P. digitatum*. The graphics show mean ± SD OD~600~ values of triplicate samples after 48 h of incubation at 24°C. Asterisks show statistical significance for positive interaction (multifactorial ANOVA *p* \< 0.01) of fungal growth inhibition for each peptide combination at the concentrations indicated below the panels.](fmicb-08-00592-g005){#F5}

To determine the possible interaction between the hexapeptide PAF26 and the antifungal peptides derived from the AfpB and PAF protein, additional combinations of peptides were tested. These experiments demonstrated that the AfpB-derived peptides PAF112 and PAF118, as well as the PAF-derived peptide PAF116, show a positive synergistic interaction with PAF26 (multifactorial ANOVA, *p* \< 0.01; **Figure [5](#F5){ref-type="fig"}**), reducing the fungal biomass when combined at non-inhibitory concentrations.

Given the synergy existing between PAF26 and the antifungal peptides derived from both AFPs, further antifungal assays were conducted to determine whether the protein PAF from *P. chrysogenum* could also interact synergistically with PAF26. Three fungi were chosen for these experiments that are representative of the sensitivity range to PAF, from the highly sensitive *A. niger* to the tolerant PAF-producer *P. chrysogenum* (**Table [3](#T3){ref-type="table"}**). The results indicated no apparent synergy in assays with *P. chrysogenum*. For *P. digitatum* and the highly PAF-sensitive *A. niger*, PAF protein showed a positive synergistic interaction with the peptide PAF26 (**Figure [6](#F6){ref-type="fig"}** and **Table [3](#T3){ref-type="table"}**). Interestingly, the three fungi did not show major differences in their sensitivity to PAF26 while they did to the PAF protein (**Table [3](#T3){ref-type="table"}**), suggesting that the PAF protein and the peptide PAF26 could have differences in their mechanism of action.

![**Synergistic interactions between the protein PAF from *P. chrysogenum* and the hexapeptide PAF26.** The synergistic interaction was tested against *P. digitatum* **(A)** and *A. niger* **(B)**. The graphics show mean ± SD OD~600~ values of triplicate samples after 48 h of incubation at 24°C. Asterisks show statistical significance for positive interaction (multifactorial ANOVA *p* \< 0.01) of fungal growth inhibition for each peptide/protein combinations at the concentrations indicated below the panels.](fmicb-08-00592-g006){#F6}

ECD Spectroscopic Analysis
--------------------------

Electronic circular dichroism spectroscopy is a sensitive tool for the study of the secondary structure of proteins and peptides. To investigate the structure of the AfpB-derived peptides, ECD spectroscopy was performed (**Figure [7](#F7){ref-type="fig"}**). ECD analyses revealed that peptides PAF109, PAF112, and PAF113 predominantly displayed unordered structure in water characterized by strong minima at 195--200 nm (**Figure [7A](#F7){ref-type="fig"}**). TFE is an organic solvent commonly used to induce intramolecular H-bonding, therefore inducing and stabilizing secondary structure of protein fragments in the absence of cooperatively stabilizing structural regions of the protein of origin. Upon addition of TFE, a minor helical contribution appeared in case of the linear peptide PAF113, reflected by a low intensity broad negative shoulder in the 220--225 nm region (**Figure [7B](#F7){ref-type="fig"}**). Since this peptide has no disulfide bond and therefore less conformational restraints, it can adapt more readily to changes in environment (for example, addition of a helix-inducing solvent). PAF119 (**Figure [7A](#F7){ref-type="fig"}**) yielded a spectrum that reports on the dominance of random structures with a minor β-sheet contribution, and a more pronounced signal from the disulfide bridge (maximum around 230 nm). Addition of TFE to PAF119 did not increase, but rather diminished β-sheet contributions.

![**ECD spectra of AfpB-derived peptides. (A)** Spectra obtained from peptides in H~2~O. **(B)** Spectra obtained from peptides solved in TFE/H~2~O (50:50) mixture. All experiments were conducted at 25°C.](fmicb-08-00592-g007){#F7}

PAF118 displayed markedly different spectra compared to those of the rest of the peptides analyzed (**Figure [7A](#F7){ref-type="fig"}**, green line). The ECD spectrum of PAF118 is dominated by contributions from antiparallel β-structure (relative maximum near 195 nm and minimum near 215 nm) and disulfide bonds (maximum at 230 nm). Addition of TFE increased the β-character of the spectrum while the presence of a positive band at around 230 nm indicative of disulfide bonds was maintained (**Figure [7B](#F7){ref-type="fig"}**). Therefore, PAF118 represents an antifungal motif from AfpB that folds by itself in an antiparallel β-structure, consistent with the structural prediction within the context of the protein (see also **Figure [2B](#F2){ref-type="fig"}**).

AfpB-Derived Peptides Show Resistance to Proteolytic Degradation
----------------------------------------------------------------

To exclude the possibility that increased sensitivity to proteolytic degradation could be the reason for limited antifungal activity, we tested the *in vitro* stability of the peptides derived from AfpB by incubation with proteinase K at different times and RP-HPLC analysis of the resultant digests. Again, we used peptide PAF26 as control as it is considered highly resistant to protease degradation ([@B22]). The RP-HPLC chromatograms (Supplementary Figure [S3](#SM3){ref-type="supplementary-material"}) showed that all the cyclic peptides derived from AfpB were, with varying degrees, resistant to protease treatment with a high dose of enzyme (5 μg/mL) (**Figure [8](#F8){ref-type="fig"}**). The antifungal peptides PAF112 and PAF118 show a degradation pattern similar to PAF26, with around 20% of peptide left after 24 h of treatment. Consistently among the different repetitions of this experiment, PAF118 showed faster degradation than PAF112. **Figure [8](#F8){ref-type="fig"}** shows a severe reduction of intact PAF118 after 1 and 2 h of treatment, which was different to the degradation of PAF112. Despite their similar antifungal activities and the presence of a disulfide bond in both sequences, PAF112 seems to be more resistant to protease degradation than PAF118. PAF113, which is a linear analog of PAF112, shows high sensitivity to proteinase K as it was completely degraded after only 1 h of treatment (**Figure [8](#F8){ref-type="fig"}**). We conclude that the presence of a disulfide bond increases PAF112 stability. Finally, the non-active peptides PAF109 and specially PAF119 were both remarkably resistant to degradation by proteinase K (**Figure [8](#F8){ref-type="fig"}**).

![**Time-dependent peptide degradation in the presence of proteinase K.** Percentage of recovery of the input peptides (5 μM) represented as mean ± SD of two replicates, determined by the resulting chromatographic peak area of the corresponding peptide after treatment with proteinase K (5 μg/mL) for different times (0, 1, 2, and 24 h).](fmicb-08-00592-g008){#F8}

Discussion
==========

Most of the studies based on peptides derived from antifungal CRPs have focused on defensins and the highly conserved γ-motif ([@B37]; [@B2]; [@B43]; [@B29]; [@B20]), but not on fungal AFPs. Our data identify for the first time synthetic peptides derived from fungal AFPs with antifungal activity. The peptides PAF112 and PAF118 derived from the *P. digitatum* AfpB and PAF116 from the *P. chrysogenum* PAF showed specific activity against selected filamentous fungi. PAF112 and PAF118 are not active against bacteria (*E. coli*) at the highest concentration tested (128 μM, **Figure [2](#F2){ref-type="fig"}**), which is consistent with the specificity profile of native AFPs that are antifungal but not antibacterial ([@B27]; [@B28]). Importantly, none of the peptides overlap in neither of the two AFPs with the conserved γ-core motif that is present in virtually all known AFPs and other defensin-like antimicrobial peptides ([@B48]). There is no correlation between the GRAVY value and the activity of the peptides designed in our study, while all the active peptides are cationic (**Tables [1](#T1){ref-type="table"}**, **[2](#T2){ref-type="table"}**). The importance of positive charge in the activity of AMPs including AFPs is well established ([@B6]; [@B26]). For example, three different mutations of the *P. chrysogenum* PAF in cationic lysine residues located at different positions resulted in loss of antifungal activity ([@B4]), and mutation of the arginine and/or lysine residues in the PAF26 sequence also abolished activity ([@B30]). However, PAF112 and PAF116 show similar antifungal activity despite differences in charge (i.e., PAF116 is markedly more cationic). Therefore, the antifungal activity of these peptides can only be partially attributed to their positive net charge (see also below).

The *P. chrysogenum* PAF is the antifungal protein that has been most extensively characterized by site-directed mutagenesis, which allowed the identification of residues important for activity ([@B4]; [@B41], [@B40]). Both PAF112 and PAF116 are located in the analogous large loop L3 of the corresponding class B protein AfpB and class A protein PAF, respectively. Although these peptides share only limited sequence identity, they represent one of the regions with highest similarity between both proteins. Mutations of Lys35 and Lys38 ([@B4]) and of Phe31 ([@B41]), which are located in this L3 loop of *P. chrysogenum* PAF, negatively affect antifungal activity. Therefore, by demonstrating the activity of isolated peptides from two different proteins (AfpB and PAF), our study contributes to establish L3 as an important domain in the antifungal activity of this class of AMPs. The peptide PAF112 is not structured (**Figure [7](#F7){ref-type="fig"}**), simulating the situation in the exposed loop L3 of the protein model, which lacks a defined canonical secondary structure (**Figures [1](#F1){ref-type="fig"}**, **[2](#F2){ref-type="fig"}**). The structural data have shown that loop L3 is a dynamic and flexible region in PAF ([@B4]; [@B12]).

The antifungal peptide PAF118 folds into an antiparallel β-sheet conformation that resembles the folding of this motif within the context of the protein. None of the previously reported mutations in residues of the PAF protein that affect the protein activity locate in the protein region analogous to PAF118 ([@B4]; [@B41]). However, very recently it has been shown that the exchange of the negatively charged Asp19 to a neutral Ser in this PAF protein domain severely reduced protein activity ([@B40]). This mutation does not disturb the overall 3D protein solution structure, but influences the surface charge distribution in distant regions of the PAF protein including the cationic L3, which most probably accounts for the loss of antifungal function ([@B40]). The primary sequence of PAF and AfpB is different in this region as for instance no anionic residues are present in AfpB, contrary to PAF. Our demonstration of activity of the isolated motif represented by PAF118 identify this as a second putative region involved in the activity of AfpB. The only two cationic residues in this peptide are located in the turn that connects the two antiparallel β-sheets, and represent candidates to determine the antifungal properties of PAF118. Future work will attempt to confirm the importance of this domain in the activity of AFP-like proteins.

On the other hand, PAF109, which contains the minimal γ-core element, did not show either antifungal or antibacterial activity with any of the microorganism tested in our study. Consistent with the archetypical γ-core motif ([@B48]), this peptide sequence spans two antiparallel β-sheets (**Figure [2B](#F2){ref-type="fig"}**). Plant defensins are related to AFPs in that they are small and cationic CRPs that have antifungal activity and contain the γ-core motif; however, their αβ fold is structurally distinct from that of AFPs ([@B43]; [@B39]). Analogous γ-core peptides from the plant defensins MtDef4 from *Medicago*, SolyC07g007760 from tomato, or BhDef2 from *Brassica* were antimicrobial ([@B37]; [@B2]; [@B20]). However, other γ-core peptides such as the two motifs derived from the *Medicago* defensin MsDef1 did not show antifungal activity against *Fusarium graminearum* ([@B37]). In previous studies, a correlation between the cationic net charge of the γ-core-derivative peptides and their antimicrobial activity was demonstrated. The peptide derivative BhDEF12M from BhDef1 protein contains asparagine to arginine substitutions that promoted antibacterial and antifungal activity ([@B20]). Yet, there are exemptions to this rule as other non-cationic γ-core peptides derived from plant defensins (i.e., BhDef23) were antimicrobial ([@B20]). In this context, PAF109 is a peptide that has low positive charge (ca. +1.1 at pH 7.0) and did not show activity. In addition, PAF109 and PAF119 are extremely stable peptides. Based on our data, we propose that the γ-core in AfpB has mainly a structural significance important for the formation of the native structure and the stability of the protein but is not necessarily associated with antimicrobial activity. However, the γ-core in the *P. chrysogenum* PAF has a higher cationic charge than the AfpB γ-core and mutation of Lys9 in the PAF protein resulted in the decrease of protein activity suggesting that this motif is important for protein function ([@B4]). Future investigations will address this apparently contradictive issue in fungal AFPs.

Antifungal activity of PAF116 is about 5--10 times weaker than the activity of the corresponding PAF protein. This finding implicates that additional motifs/sequences in the protein are required to achieve full activity. Similarly, we predict that PAF112 and PAF118 also have significantly lower activity than the elusive (non-detectable) AfpB. In order to test this hypothesis, our current efforts are directed toward the heterologous expression of the *afpB* gene to achieve protein production and purification. As an alternative approach in this study, we conducted experiments to determine whether treatment with both PAF112 and PAF118 inhibits fungal growth with potency higher than the sum of both peptides acting individually. We could demonstrate a positive synergistic interaction (**Figure [5](#F5){ref-type="fig"}**), which supports our hypothesis that both domains could cooperate to achieve the activity of the full-length protein.

It is generally established that antimicrobial compounds that have a positive synergistic interaction act on different microbial targets or have mechanisms of action that complement each other ([@B18]; [@B46]). This would be the case for the different AFP-derived and PAF26 peptides on *P. digitatum* and also for the PAF26/PAF protein combination on *A. niger* and *P. digitatum* as described in this study. Different time-course inhibition by PAF26 or AfpB-derived peptides on either *P. digitatum* or *A. niger* indicate mechanistic differences (**Figure [3](#F3){ref-type="fig"}**). The existence of at least partially different mechanisms in the combination PAF26/PAF protein is also supported by the different profile of activity among different fungal strains (**Table [3](#T3){ref-type="table"}**). Furthermore, the demonstration of synergy also opens up new alternatives to improve (i) the antifungal activity of AFPs by combined action with other unrelated peptides such as PAF26, or (ii) the rational design of novel AMPs by combination of distinct peptide sequences ([@B3]; [@B36]).

Besides, there are also common mechanistic features between AFP proteins and the unrelated synthetic peptide PAF26, such as the endocytic internalization and increased concentrations of intracellular reactive oxygen species and cytoplasmic Ca^2+^ in sensitive fungal cells ([@B27]; [@B5]; [@B8]; [@B32]). PAF26 has been proposed as a model peptide to study the mode of action of cell penetrating antifungal peptides ([@B30],[@B31]). The mechanism of PAF26 has been divided in three stages: (i) interaction with the fungal cell surface (cell wall and membrane), (ii) cellular internalization, and (iii) intracellular killing. This model framework could be useful to better refine and characterize the mechanism of AFPs and related proteins. Additionally, the identification of PAF112, PAF118, and PAF116 provides minimal motifs useful for the detailed mechanistic study of AFP-like proteins.

AFPs show remarkable thermal stability and resistance to protease degradation, which has been attributed to their tight structural packaging and disulfide bonding ([@B4]; [@B12]). Consistently with this, all the AfpB-derived peptides with disulfide bonds were stable under restrictive *in vitro* degradation experiments (**Figure [8](#F8){ref-type="fig"}**). The stability of PAF109 and PAF119 indicates that their lack of antifungal activity cannot be attributed to propensity to degradation. By characterizing the linear analog PAF113 of peptide PAF112 we confirmed that the disulfide bridge between the two cysteines greatly stabilizes the peptide toward proteolytic degradation by proteinase K ([@B2]). PAF113 shows initial antifungal activity comparable to PAF112, although the activity was gradually lost with time in some experiments (data not shown), probably as consequence of degradation. The stability of all four cyclized AfpB-derived peptides suggests a reasonable stability of the putative protein AfpB. In that case, other so far unidentified regulatory mechanisms in mRNA stability and/or protein translation could be responsible for the lack of AfpB detection in *P. digitatum* cultures.

In summary, this study identifies protein motifs involved in the specific antifungal activity of AFPs, and opens new strategies for the future use of AFP-related peptides and proteins, the development of rationally designed antifungal peptides and their use in the characterization of the antifungal activity of AFPs. Two synthetic peptides that span about the central half of AfpB, including the major L3 loop, would contribute to specific antifungal activity of the putative AfpB, whereas the γ-core motif seems to play a different functional role.
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